| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.85e-07 | 16 | 17 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.75e-07 | 21 | 17 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.42e-06 | 749 | 17 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.85e-05 | 85 | 17 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.28e-04 | 20 | 17 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 3.09e-03 | 98 | 17 | 2 | GO:0048306 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.59e-03 | 120 | 17 | 2 | GO:0004222 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 5.39e-03 | 430 | 17 | 3 | GO:0004175 | |
| GeneOntologyMolecularFunction | integrin binding | 9.53e-03 | 175 | 17 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.12e-02 | 190 | 17 | 2 | GO:0004252 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.23e-02 | 200 | 17 | 2 | GO:0008237 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.31e-02 | 207 | 17 | 2 | GO:0008236 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.33e-02 | 599 | 17 | 3 | GO:0050839 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.37e-02 | 212 | 17 | 2 | GO:0017171 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 8.01e-06 | 336 | 18 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 8.86e-06 | 343 | 18 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 3.62e-05 | 75 | 18 | 3 | GO:0022617 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 5.83e-05 | 850 | 18 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 7.21e-05 | 883 | 18 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 8.28e-05 | 276 | 18 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 9.98e-05 | 569 | 18 | 5 | GO:0034329 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.26e-04 | 308 | 18 | 4 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.28e-04 | 309 | 18 | 4 | GO:1901888 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.74e-04 | 377 | 18 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.77e-04 | 378 | 18 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.80e-04 | 379 | 18 | 4 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.84e-04 | 412 | 18 | 4 | GO:0090287 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 5.14e-04 | 445 | 18 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 5.85e-04 | 192 | 18 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 6.07e-04 | 42 | 18 | 2 | GO:0099560 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 6.11e-04 | 195 | 18 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 6.78e-04 | 202 | 18 | 3 | GO:0051963 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 6.95e-04 | 482 | 18 | 4 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 7.92e-04 | 48 | 18 | 2 | GO:0021696 | |
| GeneOntologyBiologicalProcess | MAPK cascade | 9.66e-04 | 930 | 18 | 5 | GO:0000165 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.19e-03 | 974 | 18 | 5 | GO:0034330 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 1.24e-03 | 60 | 18 | 2 | GO:0021587 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 1.24e-03 | 249 | 18 | 3 | GO:0010976 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 1.40e-03 | 64 | 18 | 2 | GO:0021575 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to plasma membrane | 1.68e-03 | 70 | 18 | 2 | GO:1903078 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 1.72e-03 | 71 | 18 | 2 | GO:0021695 | |
| GeneOntologyBiologicalProcess | signal release | 2.14e-03 | 653 | 18 | 4 | GO:0023061 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell periphery | 2.29e-03 | 82 | 18 | 2 | GO:1904377 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.38e-03 | 313 | 18 | 3 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of protein binding | 2.46e-03 | 85 | 18 | 2 | GO:0032092 | |
| GeneOntologyBiologicalProcess | synapse organization | 2.54e-03 | 685 | 18 | 4 | GO:0050808 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 2.85e-03 | 1186 | 18 | 5 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 2.88e-03 | 1189 | 18 | 5 | GO:0044087 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.93e-03 | 1194 | 18 | 5 | GO:0000902 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 2.94e-03 | 93 | 18 | 2 | GO:0099068 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 2.94e-03 | 337 | 18 | 3 | GO:0006898 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.19e-03 | 347 | 18 | 3 | GO:0090092 | |
| GeneOntologyBiologicalProcess | protein K48-linked ubiquitination | 3.38e-03 | 100 | 18 | 2 | GO:0070936 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 3.50e-03 | 748 | 18 | 4 | GO:0048667 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 3.97e-03 | 375 | 18 | 3 | GO:0007162 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 4.22e-03 | 1299 | 18 | 5 | GO:1902533 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 4.28e-03 | 385 | 18 | 3 | GO:0070372 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 4.34e-03 | 387 | 18 | 3 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 4.46e-03 | 1316 | 18 | 5 | GO:0032101 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 4.49e-03 | 802 | 18 | 4 | GO:0048812 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 4.59e-03 | 395 | 18 | 3 | GO:0050803 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 4.75e-03 | 815 | 18 | 4 | GO:0043408 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 4.79e-03 | 817 | 18 | 4 | GO:0048514 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 4.84e-03 | 819 | 18 | 4 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 4.99e-03 | 826 | 18 | 4 | GO:0048858 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.80e-04 | 384 | 18 | 4 | GO:0030139 | |
| GeneOntologyCellularComponent | distal axon | 4.49e-04 | 435 | 18 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | axonal growth cone | 6.78e-04 | 45 | 18 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | growth cone | 1.14e-03 | 245 | 18 | 3 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.25e-03 | 253 | 18 | 3 | GO:0030427 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.13e-03 | 80 | 18 | 2 | GO:0005905 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.76e-03 | 107 | 18 | 2 | GO:0060076 | |
| Domain | ASX_HYDROXYL | 2.34e-08 | 100 | 17 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.14e-08 | 106 | 17 | 5 | IPR000152 | |
| Domain | EGF | 4.10e-08 | 235 | 17 | 6 | SM00181 | |
| Domain | EGF_3 | 4.10e-08 | 235 | 17 | 6 | PS50026 | |
| Domain | EGF-like_dom | 5.79e-08 | 249 | 17 | 6 | IPR000742 | |
| Domain | EGF_1 | 6.66e-08 | 255 | 17 | 6 | PS00022 | |
| Domain | EGF-like_CS | 7.65e-08 | 261 | 17 | 6 | IPR013032 | |
| Domain | EGF_2 | 8.37e-08 | 265 | 17 | 6 | PS01186 | |
| Domain | Ldl_recept_b | 2.27e-07 | 14 | 17 | 3 | PF00058 | |
| Domain | LDLRB | 2.27e-07 | 14 | 17 | 3 | PS51120 | |
| Domain | LY | 2.83e-07 | 15 | 17 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.83e-07 | 15 | 17 | 3 | IPR000033 | |
| Domain | DUF5050 | 7.80e-07 | 2 | 17 | 2 | PF16472 | |
| Domain | DUF5050 | 7.80e-07 | 2 | 17 | 2 | IPR032485 | |
| Domain | EGF_CA | 9.53e-07 | 86 | 17 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.54e-06 | 97 | 17 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.68e-06 | 99 | 17 | 4 | PS01187 | |
| Domain | EGF_CA | 3.86e-06 | 122 | 17 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.12e-06 | 124 | 17 | 4 | IPR001881 | |
| Domain | EGF | 4.39e-06 | 126 | 17 | 4 | PF00008 | |
| Domain | - | 5.61e-06 | 39 | 17 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 6.06e-06 | 40 | 17 | 3 | IPR023415 | |
| Domain | Ldl_recept_a | 8.68e-06 | 45 | 17 | 3 | PF00057 | |
| Domain | - | 9.28e-06 | 46 | 17 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.28e-06 | 46 | 17 | 3 | IPR011042 | |
| Domain | Growth_fac_rcpt_ | 1.02e-05 | 156 | 17 | 4 | IPR009030 | |
| Domain | LDLRA_1 | 1.06e-05 | 48 | 17 | 3 | PS01209 | |
| Domain | LDLa | 1.12e-05 | 49 | 17 | 3 | SM00192 | |
| Domain | LDLRA_2 | 1.12e-05 | 49 | 17 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.12e-05 | 49 | 17 | 3 | IPR002172 | |
| Domain | cEGF | 2.50e-04 | 26 | 17 | 2 | PF12662 | |
| Domain | cEGF | 2.50e-04 | 26 | 17 | 2 | IPR026823 | |
| Domain | EGF_extracell | 1.34e-03 | 60 | 17 | 2 | IPR013111 | |
| Domain | EGF_2 | 1.34e-03 | 60 | 17 | 2 | PF07974 | |
| Domain | - | 2.42e-03 | 81 | 17 | 2 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.42e-03 | 81 | 17 | 2 | IPR024079 | |
| Domain | ZINC_PROTEASE | 3.52e-03 | 98 | 17 | 2 | PS00142 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 7.10e-05 | 13 | 14 | 2 | M42551 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.70e-04 | 300 | 14 | 4 | M610 | |
| Pubmed | 4.22e-08 | 14 | 18 | 3 | 15082773 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.54e-07 | 21 | 18 | 3 | 21337463 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.53e-07 | 2 | 18 | 2 | 15963947 | |
| Pubmed | Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice. | 2.53e-07 | 2 | 18 | 2 | 15327526 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 11931574 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 18277139 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 18367731 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 15863833 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 15840700 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 8013374 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 12746448 | ||
| Pubmed | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. | 2.53e-06 | 5 | 18 | 2 | 18992221 | |
| Pubmed | Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. | 2.53e-06 | 5 | 18 | 2 | 23959870 | |
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 30700132 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 18685438 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 16478678 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 12169628 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 23760271 | ||
| Pubmed | 7.07e-06 | 8 | 18 | 2 | 10380922 | ||
| Pubmed | 9.09e-06 | 9 | 18 | 2 | 20005821 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 9.09e-06 | 9 | 18 | 2 | 7544347 | |
| Pubmed | 1.39e-05 | 11 | 18 | 2 | 24639464 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.88e-05 | 101 | 18 | 3 | 23382219 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 2.29e-05 | 14 | 18 | 2 | 17389516 | |
| Pubmed | 3.85e-05 | 18 | 18 | 2 | 10827173 | ||
| Pubmed | 1.58e-04 | 36 | 18 | 2 | 20587546 | ||
| Pubmed | 3.91e-04 | 1285 | 18 | 5 | 35914814 | ||
| Pubmed | 4.66e-04 | 730 | 18 | 4 | 34857952 | ||
| Interaction | ZNF408 interactions | 7.27e-06 | 145 | 18 | 4 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 1.70e-05 | 57 | 18 | 3 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 1.98e-05 | 60 | 18 | 3 | int:ANKRD36B | |
| Interaction | ZNF563 interactions | 4.95e-05 | 12 | 18 | 2 | int:ZNF563 | |
| Interaction | SYT1 interactions | 1.06e-04 | 105 | 18 | 3 | int:SYT1 | |
| Interaction | MMP16 interactions | 1.14e-04 | 18 | 18 | 2 | int:MMP16 | |
| Interaction | NTN5 interactions | 2.06e-04 | 24 | 18 | 2 | int:NTN5 | |
| Interaction | ZNF517 interactions | 3.02e-04 | 29 | 18 | 2 | int:ZNF517 | |
| Interaction | ELFN2 interactions | 3.02e-04 | 29 | 18 | 2 | int:ELFN2 | |
| Interaction | MMP13 interactions | 3.45e-04 | 31 | 18 | 2 | int:MMP13 | |
| Interaction | ZNF74 interactions | 4.16e-04 | 34 | 18 | 2 | int:ZNF74 | |
| Interaction | LDLR interactions | 4.39e-04 | 417 | 18 | 4 | int:LDLR | |
| Interaction | LPL interactions | 4.41e-04 | 35 | 18 | 2 | int:LPL | |
| Interaction | RNF187 interactions | 4.66e-04 | 36 | 18 | 2 | int:RNF187 | |
| Interaction | MZF1 interactions | 4.93e-04 | 37 | 18 | 2 | int:MZF1 | |
| Interaction | LRPAP1 interactions | 5.18e-04 | 180 | 18 | 3 | int:LRPAP1 | |
| GeneFamily | Low density lipoprotein receptors | 6.36e-08 | 13 | 12 | 3 | 634 | |
| GeneFamily | Ring finger proteins | 1.38e-02 | 275 | 12 | 2 | 58 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 9.26e-06 | 200 | 18 | 4 | M6629 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | 8.77e-05 | 703 | 18 | 5 | M39070 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.43e-04 | 780 | 18 | 5 | M2324 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.55e-04 | 27 | 18 | 2 | M14833 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.66e-04 | 805 | 18 | 5 | MM1067 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.32e-04 | 33 | 18 | 2 | MM477 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN | 3.05e-04 | 195 | 18 | 3 | M9309 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP | 3.23e-04 | 199 | 18 | 3 | M9351 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP | 3.23e-04 | 199 | 18 | 3 | M5203 | |
| Coexpression | GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 3.28e-04 | 200 | 18 | 3 | M6990 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 8.53e-06 | 974 | 18 | 7 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.01e-05 | 166 | 18 | 4 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#3 | 2.37e-05 | 67 | 18 | 3 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 4.24e-05 | 489 | 18 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.90e-05 | 271 | 18 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | cerebral cortex | 1.01e-04 | 1428 | 18 | 7 | cerebral cortex | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#3_top-relative-expression-ranked_100 | 1.55e-04 | 22 | 18 | 2 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_100_k3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-06 | 199 | 18 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 142 | 18 | 3 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 142 | 18 | 3 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.40e-05 | 159 | 18 | 3 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-05 | 163 | 18 | 3 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-05 | 163 | 18 | 3 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 3.93e-05 | 167 | 18 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | droplet-Heart-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 169 | 18 | 3 | 2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-05 | 170 | 18 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.37e-05 | 173 | 18 | 3 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 174 | 18 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 174 | 18 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.52e-05 | 175 | 18 | 3 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.52e-05 | 175 | 18 | 3 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.08e-05 | 182 | 18 | 3 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 184 | 18 | 3 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 184 | 18 | 3 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-05 | 186 | 18 | 3 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 188 | 18 | 3 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 188 | 18 | 3 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.59e-05 | 188 | 18 | 3 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.68e-05 | 189 | 18 | 3 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.68e-05 | 189 | 18 | 3 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.68e-05 | 189 | 18 | 3 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-GAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 191 | 18 | 3 | 1f5d1e8c313a8dc83c06d2ee45f369b0ec507fbf | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.86e-05 | 191 | 18 | 3 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | b5210de890d338602857b5907135705a507bc2b0 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.86e-05 | 191 | 18 | 3 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.86e-05 | 191 | 18 | 3 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | c715bbdbbf1482aad45a50a16d5232fd35a9a0bb | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-05 | 191 | 18 | 3 | 243d83cbfcc4996ad087ec6386e559e0b8662004 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.96e-05 | 192 | 18 | 3 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.96e-05 | 192 | 18 | 3 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.96e-05 | 192 | 18 | 3 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.96e-05 | 192 | 18 | 3 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.96e-05 | 192 | 18 | 3 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 192 | 18 | 3 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.05e-05 | 193 | 18 | 3 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | eb3c46b6fb06dc8708dc3032189b47ed93ee2357 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.05e-05 | 193 | 18 | 3 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.05e-05 | 193 | 18 | 3 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-05 | 193 | 18 | 3 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-05 | 193 | 18 | 3 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | b45cd02081f97904eaea2d013e1fa980505d060b | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 194 | 18 | 3 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 194 | 18 | 3 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 194 | 18 | 3 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.24e-05 | 195 | 18 | 3 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 196 | 18 | 3 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-05 | 196 | 18 | 3 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-05 | 196 | 18 | 3 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 197 | 18 | 3 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-05 | 198 | 18 | 3 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-05 | 198 | 18 | 3 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 198 | 18 | 3 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-05 | 198 | 18 | 3 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-05 | 199 | 18 | 3 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.62e-05 | 199 | 18 | 3 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-05 | 199 | 18 | 3 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.62e-05 | 199 | 18 | 3 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.52e-04 | 108 | 18 | 2 | 4536cbe1748aee37f0a13648c5679fd592af6322 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.81e-04 | 116 | 18 | 2 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-03 | 128 | 18 | 2 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.21e-03 | 129 | 18 | 2 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-03 | 130 | 18 | 2 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-03 | 133 | 18 | 2 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|RA / Chamber and Cluster_Paper | 1.31e-03 | 134 | 18 | 2 | 60ee3accc54108e5b9a0018f6aa8488dc39d5ade | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-3|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.34e-03 | 136 | 18 | 2 | 4f5e0b6c7d6e3e922af4daa7c3eb56490455c1df | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.38e-03 | 138 | 18 | 2 | 5a713f24f633de463ef47ca37fbb2bb60c7fdb77 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-03 | 139 | 18 | 2 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-03 | 139 | 18 | 2 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-03 | 140 | 18 | 2 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-03 | 142 | 18 | 2 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-03 | 143 | 18 | 2 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 144 | 18 | 2 | 121853910eeea1ea0642b3cc99f9200015480368 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-03 | 145 | 18 | 2 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-03 | 145 | 18 | 2 | 88e463d5396a8fea2b7b1ecf3c9b144e16b35234 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-03 | 145 | 18 | 2 | 911fee7f27694393e348d94470a1a4e890038902 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-03 | 145 | 18 | 2 | 07acbf086cffce0628accf078d31bf190f803988 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-03 | 146 | 18 | 2 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-03 | 148 | 18 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.51e-05 | 197 | 18 | 4 | 4729_UP | |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | 1.54e-05 | 198 | 18 | 4 | 4468_DN | |
| Drug | 1-4a | 2.29e-05 | 71 | 18 | 3 | CID000657007 | |
| Drug | Succimer | 2.96e-05 | 1264 | 18 | 7 | ctd:D004113 | |
| Drug | Magnetite Nanoparticles | 3.73e-05 | 1310 | 18 | 7 | ctd:D058185 | |
| Drug | troglitazone | 4.31e-05 | 526 | 18 | 5 | CID000005591 | |
| Drug | monatepil | 2.37e-04 | 29 | 18 | 2 | CID000060810 | |
| Drug | probucol | 2.67e-04 | 162 | 18 | 3 | CID000004912 | |
| Drug | ethylnylestradiol | 2.85e-04 | 1251 | 18 | 6 | CID000003285 | |
| Drug | Cyclosporin A [59865-13-3]; Up 200; 3.4uM; MCF7; HT_HG-U133A | 3.02e-04 | 169 | 18 | 3 | 4411_UP | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; HL60; HT_HG-U133A | 3.35e-04 | 175 | 18 | 3 | 2507_UP | |
| Drug | DNOC | 3.46e-04 | 35 | 18 | 2 | CID000010800 | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.81e-04 | 183 | 18 | 3 | 3480_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 4.19e-04 | 189 | 18 | 3 | 5586_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 4.26e-04 | 190 | 18 | 3 | 4274_UP | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A | 4.26e-04 | 190 | 18 | 3 | 7145_UP | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 4.39e-04 | 192 | 18 | 3 | 3391_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 4.39e-04 | 192 | 18 | 3 | 4303_UP | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 4146_UP | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 6733_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 3900_UP | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 6667_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 4746_UP | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3368_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3256_UP | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 6501_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 6934_UP | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 4154_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4181_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2839_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5106_UP | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6814_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3355_UP | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3388_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 3803_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 3718_UP | |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 7166_UP | |
| Disease | facial attractiveness measurement | 5.31e-05 | 19 | 17 | 2 | EFO_0009892 | |
| Disease | keratoconus | 6.56e-04 | 66 | 17 | 2 | MONDO_0015486 | |
| Disease | schizophrenia (implicated_via_orthology) | 6.96e-04 | 68 | 17 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.00e-03 | 447 | 17 | 3 | EFO_0000694, MONDO_0100096 | |
| Disease | carotid artery intima media thickness | 2.04e-03 | 450 | 17 | 3 | EFO_0007117 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.58e-03 | 132 | 17 | 2 | DOID:10652 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 3.91e-03 | 163 | 17 | 2 | DOID:1826 (implicated_via_orthology) | |
| Disease | pain | 5.59e-03 | 196 | 17 | 2 | EFO_0003843 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEPEEENDPDGPCAF | 386 | Q52LR7 | |
| PPEPSDMPCADDECF | 281 | P0C7U0 | |
| EEFCDGRHPECPEDA | 476 | P78325 | |
| EGDDVDCAPSSPCPD | 221 | Q86YS3 | |
| EDDCPDPPALFSGDA | 121 | Q6PII5 | |
| HDPDDEPDCAPPFDF | 351 | Q13164 | |
| EPDCAPPFDFAFDRE | 356 | Q13164 | |
| AECPSDDEDIDPCEP | 351 | P58400 | |
| LCDGDPDCPDDSDES | 51 | Q9NZR2 | |
| DCGDGSDEPDDCPEF | 3341 | Q9NZR2 | |
| EDDCGDHSDEPPDCP | 3356 | Q07954 | |
| AECPSDDEDIDPCEP | 1356 | Q9ULB1 | |
| ACEEDVDECAQEPPP | 706 | Q8N2S1 | |
| EPDAPPDACEASFDA | 286 | P24347 | |
| CELCPEEEPDDQDAP | 2471 | Q93008 | |
| PFDDDDGPVDCDCPA | 131 | A6NNA2 | |
| GTCDECEPDEAPGAE | 16 | Q96DX7 | |
| AEEDGPFPCPECADD | 41 | Q5TA31 | |
| AEGDFSDPCACEPGH | 346 | Q2MJR0 | |
| DDAEPEPDQGDPGAC | 171 | Q9BQ83 | |
| CDGDPDCEDGSDESP | 91 | P98155 |